Antares Pharma reported $212.62M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Adamas Pharmaceuticals ADMS:US 143.98M 6.67M
Adma Biologics ADMA:US $ 238.64M 5.83M
Aerie Pharmaceuticals AERI:US $ 351.8M 3.73M
Ani Pharmaceuticals ANIP:US $ 470.45M 9.7M
Atrion ATRI:US 268.93M 1.3M
Becton, Dickinson and BDX:US $ 53866M 467M
Biodelivery Sciences International BDSI:US $ 256.07M 5.74M
Cara Therapeutics CARA:US $ 225.09M 3.64M
Cerus CERS:US $ 218.95M 4.28M
Eli Lilly And LLY:US $ 48187M 378M
Endo International Ordinary Shares ENDP:US $ 9246.55M 40.3M
Horizon Pharma HZNP:US $ 8608.69M 401.27M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
Meridian Bioscience VIVO:US $ 449.72M 3.15M
Orasure Technologies OSUR:US $ 455.76M 9.29M
Pacira Pharmaceuticals PCRX:US $ 1356M 30.17M
Revance Therapeutics RVNC:US $ 581.83M 59.05M
Sientra SIEN:US $ 186.66M 3.87M
Staar Surgical STAA:US $ 324.6M 30.17M
Supernus Pharmaceuticals SUPN:US $ 1555.04M 18.02M
Teva Pharmaceutical TEVA:IT 47.85B 1.34B
Teva Pharmaceutical Industries TEVA:US $ 47851M 1344M
Utah Medical Products UTMD:US $ 119.75M 5.36M
Zogenix ZGNX:US $ 496.99M 43.09M